IH Quote, Financials, Valuation and Earnings

Big Tree Cloud Holdings has a net margin of 12.6% compared to iHuman's net margin of --. iHuman's return on equity of 11.1% beat Big Tree Cloud Holdings's return on equity of --.

iHuman has a consensus price target of --, signalling upside risk potential of 57.64%. On the other hand Big Tree Cloud Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that iHuman has higher upside potential than Big Tree Cloud Holdings, analysts believe iHuman is more attractive than Big Tree Cloud Holdings.

iHuman has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Big Tree Cloud Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

iHuman has a quarterly dividend of $0.10 per share corresponding to a yield of 0%. Big Tree Cloud Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iHuman pays 35.77% of its earnings as a dividend. Big Tree Cloud Holdings pays out -- of its earnings as a dividend. iHuman's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

iHuman quarterly revenues are $28.9M, which are larger than Big Tree Cloud Holdings quarterly revenues of --. iHuman's net income of $3.6M is higher than Big Tree Cloud Holdings's net income of --. Notably, iHuman's price-to-earnings ratio is 9.14x while Big Tree Cloud Holdings's PE ratio is 47.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iHuman is 1.05x versus 20.22x for Big Tree Cloud Holdings. Usually stocks with elevated PS ratios are considered overvalued.

PHH Corporation has a net margin of 12.6% compared to iHuman's net margin of --. iHuman's return on equity of 11.1% beat PHH Corporation's return on equity of --.

iHuman has a consensus price target of --, signalling upside risk potential of 57.64%. On the other hand PHH Corporation has an analysts' consensus of -- which suggests that it could fall by --. Given that iHuman has higher upside potential than PHH Corporation, analysts believe iHuman is more attractive than PHH Corporation.

iHuman has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison PHH Corporation has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

iHuman has a quarterly dividend of $0.10 per share corresponding to a yield of 0%. PHH Corporation offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iHuman pays 35.77% of its earnings as a dividend. PHH Corporation pays out -- of its earnings as a dividend. iHuman's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

iHuman quarterly revenues are $28.9M, which are larger than PHH Corporation quarterly revenues of --. iHuman's net income of $3.6M is higher than PHH Corporation's net income of --. Notably, iHuman's price-to-earnings ratio is 9.14x while PHH Corporation's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iHuman is 1.05x versus -- for PHH Corporation. Usually stocks with elevated PS ratios are considered overvalued.

Shineco has a net margin of 12.6% compared to iHuman's net margin of -36900.97%. iHuman's return on equity of 11.1% beat Shineco's return on equity of -99.67%.

iHuman has a consensus price target of --, signalling upside risk potential of 57.64%. On the other hand Shineco has an analysts' consensus of -- which suggests that it could fall by --. Given that iHuman has higher upside potential than Shineco, analysts believe iHuman is more attractive than Shineco.

iHuman has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Shineco has a beta of -0.912, suggesting its less volatile than the S&P 500 by 191.165%.

iHuman has a quarterly dividend of $0.10 per share corresponding to a yield of 0%. Shineco offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iHuman pays 35.77% of its earnings as a dividend. Shineco pays out -- of its earnings as a dividend. iHuman's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

iHuman quarterly revenues are $28.9M, which are larger than Shineco quarterly revenues of $41K. iHuman's net income of $3.6M is higher than Shineco's net income of -$15.1M. Notably, iHuman's price-to-earnings ratio is 9.14x while Shineco's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iHuman is 1.05x versus 0.01x for Shineco. Usually stocks with elevated PS ratios are considered overvalued.

Tantech Holdings has a net margin of 12.6% compared to iHuman's net margin of --. iHuman's return on equity of 11.1% beat Tantech Holdings's return on equity of --.

iHuman has a consensus price target of --, signalling upside risk potential of 57.64%. On the other hand Tantech Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that iHuman has higher upside potential than Tantech Holdings, analysts believe iHuman is more attractive than Tantech Holdings.

iHuman has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tantech Holdings has a beta of 0.491, suggesting its less volatile than the S&P 500 by 50.876%.

iHuman has a quarterly dividend of $0.10 per share corresponding to a yield of 0%. Tantech Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iHuman pays 35.77% of its earnings as a dividend. Tantech Holdings pays out -- of its earnings as a dividend. iHuman's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

iHuman quarterly revenues are $28.9M, which are larger than Tantech Holdings quarterly revenues of --. iHuman's net income of $3.6M is higher than Tantech Holdings's net income of --. Notably, iHuman's price-to-earnings ratio is 9.14x while Tantech Holdings's PE ratio is 0.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iHuman is 1.05x versus 0.03x for Tantech Holdings. Usually stocks with elevated PS ratios are considered overvalued.